+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Transcatheter left atrial appendage closure for stroke prevention among atrial fibrillation patients



Transcatheter left atrial appendage closure for stroke prevention among atrial fibrillation patients



Expert Review of Cardiovascular Therapy 10(7): 819-821




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056633965

Download citation: RISBibTeXText

PMID: 22908912

DOI: 10.1586/erc.12.70


Related references

The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. Journal of the American College of Cardiology 59(10): 923-929, 2012

Safety and Efficacy of Transcatheter Left Atrial Appendage Closure for Stroke Prevention in Patients with Atrial Fibrillation. Progress in Cardiovascular Diseases 60(4-5): 542-549, 2018

Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation. European Heart Journal 33(6): 698-704, 2012

Transcatheter left atrial appendage closure for stroke prevention in atrial fibrillation with Amplatzer cardiac plug: the Belgian Registry. Acta Cardiologica 68(6): 551-558, 2013

Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation 127(6): 720-729, 2013

Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation. Journal of the American College of Cardiology 61(17): 1790-1798, 2013

Percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation: is left atrial appendage closure an alternative for anticoagulation?. Nederlands Tijdschrift Voor Geneeskunde 162:, 2018

Transcatheter left atrial appendage occlusion in the prevention of stroke and death in patients with atrial fibrillation. Kardiologia Polska 72(11): 1127-1134, 2014

Transcatheter left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: results from the Belgian registry. Eurointervention 13(13): 1603-1611, 2018

Is left atrial appendage closure useful for stroke prevention in atrial fibrillation patients with renal failure?. International Journal of Cardiology 216: 186-187, 2016

Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation. International Journal of Cardiology 249: 234-246, 2017

Left atrial appendage closure for stroke prevention in patients with atrial fibrillation and hereditary hemorrhagic telangiectasia. Case Reports in Cardiology 2012: 646505, 2012

Minimally Invasive Closure of the Left Atrial Appendage: A Non-Pharmacologic Approach to Prevention of Stroke in Patients with Atrial Fibrillation. Rhode Island Medical Journal 100(5): 23-26, 2017

Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit. European Heart Journal 33(21): 2700-2708, 2012

Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation Patients With Contraindications to Anticoagulation. Canadian Journal of Cardiology 32(11): 1355.E9, 2016